Lori Baker
LightNews LightNews
banner
loribaker.bsky.social
Lori Baker
@loribaker.bsky.social
130 followers 630 following 13 posts
Associate Director Thought Leader Strategic Marketing Liaison at Calliditas | Views are my own
#NephSky
Posts Replies Media Videos
Reposted by Lori Baker
anujajava.bsky.social
Sequel of our collaborative work on the role of complement in preeclampsia is out:

www.nature.com/articles/s41...
Understanding rare genetic variants within the terminal pathway of complement system in preeclampsia - Genes & Immunity
Genes & Immunity - Understanding rare genetic variants within the terminal pathway of complement system in preeclampsia
www.nature.com
January 5, 2025 at 10:32 PM
Reposted by Lori Baker
nephrosparks.bsky.social
Spring is coming #NephMadness
January 23, 2025 at 8:59 PM
Reposted by Lori Baker
nephmadness.bsky.social
COMING SOON: #NephMadness 2025 starts on March 1!

Get to know the Executive Team on the #AJKDBlog:

bit.ly/3PIJRhI

@annaburgner.bsky.social
@jrkott27.bsky.social
@nephrosparks.bsky.social
@kidneywars.bsky.social
Elena Cervantes
Ana Catalina Alvarez-Elías
Krithika Mohan
Dia Waguespack
#NephMadness 2025: Meet the Gamemakers
We are a few weeks out from the launch of the 13th NephMadness! This year’s Executive Team features plenty of familiar faces, as well as a few new ones.  These are the folks that have been wo…
bit.ly
January 23, 2025 at 2:51 PM
Reposted by Lori Baker
saynanorouzi.bsky.social
Next month, I will be moderating a case-based discussion on IgA nephropathy at HCPLive. It's a timely conversation about the available therapies for this condition. Really excited ⭐️😍 #Nephsky

You can sign up here (Free registration):👇

event.hcplive.com/event/4e2c7f...
January 24, 2025 at 6:21 PM
loribaker.bsky.social
👀👇👏
January 25, 2025 at 6:57 AM
Reposted by Lori Baker
saynanorouzi.bsky.social
Happy New Year!!
How to start 2025?! With an amazing lecture by Dr. Rovin ⭐️🤯 @glomcon.org Fellowship program.

🚨New FDA approved meds for IgAN
🚨Love-hate relationship with steroids

Nothing lasts forever 😄😉 #Glomlovers
January 2, 2025 at 4:27 PM
Reposted by Lori Baker
nephjc.bsky.social
As we welcome 2025 and say goodbye to 2024- another amazing year in nephrology- you the #NephJC community voted for them...
Here are the top NEPHROLOGY stories of 2024! Join us 9pm EST on 1/7/25 as we chat about what were practice and life changing events of the past year. #NephSky #MedSky
January 1, 2025 at 4:09 PM
Reposted by Lori Baker
rheaultm.bsky.social
Two years ago, we pointed out a glaring lack of women editors at UpToDate nephrology.

To their credit they’ve made significant progress with now 14 women included. www.uptodate.com/contents/aut...

Speak out. Your voice can drive real change.
Tweet from 2022 pointing out that UpToDate nephrology had 0 women out of 35 editors at the time.
December 10, 2024 at 3:52 AM
Reposted by Lori Baker
brendonneuen.bsky.social
The PARASOL initiative started after the DUPLEX trial results were presented by @rheaultm.bsky.social in 2023

On #kidneycompass, Laura Mariani shares how remarkable progress can be possible in a short time when groups work together towards a common goal #FSGS

www.hcplive.com/view/kidney-...
Kidney Compass: PARASOL Background and FSGS Landscape
In part 2 of 4 from this episode, the discussion focuses on the groundbreaking work of the RADAR Registry and the PARASOL Initiative.
www.hcplive.com
December 12, 2024 at 2:40 AM
Reposted by Lori Baker
drdeidracrews.bsky.social
It's that time of year again, #NephSky, time to nominate your deserving colleague for an @asnkidney.bsky.social award! Nominations are due Jan 24th.

www.asn-online.org/about/awards/
American Society of Nephrology | Awards - Home
Get information on ASN awards, deadlines, and recipients.
www.asn-online.org
December 13, 2024 at 4:58 AM
Reposted by Lori Baker
nidiamessias.bsky.social
So very happy with this publication! I hope it will assist trainees in #nephrology and #renalpath in the uses of IF.

karger.com/gdz/article/...
Immunofluorescence Use and Techniques in Glomerular Diseases: A Review
Abstract. Background: Immunofluorescence (IF) studies play an essential role in the evaluation of medical renal biopsies. Particularly, in the study of renal glomerular diseases, where it provides fun...
karger.com
December 13, 2024 at 2:04 PM
Reposted by Lori Baker
jwaitz.bsky.social
This is how you know you’ve hit middle age: it’s not when the music of your youth is played in grocery stores, but instead, when it is used to promote age-appropriate cancer screening.

www.cologuard.com/getlow2

#medsky
Lil Jon and Cologuard Get Low | Cologuard Patient Site
It's time to Get Low with Lil Jon and Cologuard. Learn more about Get Low #2 and how to order your Cologuard test to get ahead of colon cancer...
www.cologuard.com
December 14, 2024 at 12:33 PM
Reposted by Lori Baker
mannonmom.bsky.social
You know when you have one of those days? And then you see this in your insta feed and realize, "it'll be ok".
www.instagram.com/reel/DDhx_s0... @glaucomflecken.bsky.social please post up on BSKY because the #nephrology world is present and nearly all accounted for!
Login • Instagram
Welcome back to Instagram. Sign in to check out what your friends, family & interests have been capturing & sharing around the world.
www.instagram.com
December 14, 2024 at 3:30 PM
Reposted by Lori Baker
nkf-professionals.bsky.social
💡 Discover opportunities.
🤝 Network w/experts.

Attend the #Fellows Reception during #NKFClinicals! Meet nephrologists from diverse career paths & gain advice to shape your future.

📅 When: 4/9/25, 5 PM - 7 PM
📍 Where: Boston - SCM25

👉 Register now: bit.ly/NKFSCM25
December 16, 2024 at 1:48 PM
Reposted by Lori Baker
ajkd.bsky.social
New on the #AJKDBlog:

Timothy Yau interviews Dr. Anuja Java about Clinical Genetic Testing in Nephrology: Core Curriculum 2024

https://bit.ly/3VtjcZp (FREE)
December 16, 2024 at 11:00 PM
Reposted by Lori Baker
garysinger.bsky.social
Donate and gear up to help end #FoodInsecurity
#HCWvsHunger
#UrineItToWinIt

www.nephjc.com/news/2021/12...
December 1, 2024 at 12:41 AM
Reposted by Lori Baker
brianrifkin.bsky.social
Hey #NephSky!
It’s that time of year again (no, not Chrisma-Hannu-Kwanza)…
Time to vote for the top nephrology stories of 2024 🏆!
We’ve done 23 NephJC chats to date, or maybe you have 1 that we forgot. Let us know with #TopNephrology & watch for the #NephJC newsletter to rank’em.
a cartoon envelope with a paper in it that says `` the award goes to ... '' .
ALT: a cartoon envelope with a paper in it that says `` the award goes to ... '' .
media.tenor.com
December 2, 2024 at 12:38 PM
Reposted by Lori Baker
brianrifkin.bsky.social
Be safe out there today people. For goodness sake, if you are able, treat yourself to a round of (a)sausage. 🫠
PS Yes, we are just living in the Matrix #NephSky
November 12, 2024 at 12:59 PM
Reposted by Lori Baker
dailyhemo.bsky.social
Data from a pair of studies presented at the ASN Kidney Week 2023 are offering further insight into the potential of budesonide delayed-release capsules (Tarpeyo) in the management of primary IgA nephropathy. www.hcplive.com/view/budeson... #MedSky #HealthSky #NephSky #KidneyWk #PharmaSky
Budesonide Reduces eGFR Decline, Effect Could Prevent Clinical Events in IgA Nephropathy
Data for a pair of studies presented at Kidney Week 2023 provide an overview of the effects of eGFR and how this might translate to potential long-term benefit in patients IgA nephropathy.
www.hcplive.com
November 4, 2023 at 10:46 PM
loribaker.bsky.social
Hello #NephSky!
November 12, 2024 at 1:51 AM